In addition to stability and delivery challenges, peptides, particularly those derived from non-human sources, carry the risk of triggering immune responses
Neal recommends: Regular monitoring: Weighing yourself at least once a week
Tirzepatide (Dual GLP-1/GIP Receptor Agonist) Tirzepatide is sometimes grouped with GLP-1 drugs, although mechanistically it is a dual agonist that activates both the GLP-1 and GIP receptors
Many researchs showed that GLP-1R signaling inhibits the innate immune response in animal models of asthma, by the activation of PKA/NF-B signaling pathway (99) and the decreased eosinophil production of IL-4, IL-8 and IL-13 (100, 101)
And if you were taking it for a medical reason like type 2 diabetes, then you may want to discuss a monitoring schedule with your doctor
J Clin Endocrinol Metab.2007;92:17151723 Rosenfeldt F, Marasco S, Lyon W, Wowk M, Sheeran F, et al